United Kingdom· GB-APID-4015711000001102
Somatuline Autogel 90mg/0.3ml solution for injection pre-filled syringes
A lanreotide product containing lanreotide, registered in United Kingdom by Ipsen Ltd. The same ATC class is registered in 17 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Lanreotide is registered in 17 of 19 countries.
Countries holding a registration under ATC H01CB03 (lanreotide), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Lanreotide · ATC H01CB03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lanreotide costs, country by country.
Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lanreotide · price per daily dose (3 mg)
USD · FX 28 Sept 2026
- FR France$53.80
- CH Switzerland$44.46
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Lanreotide
- Manufacturer
- Ipsen Ltd
- Country
- United Kingdom (GB)
- ATC code
- H01CB03
- ATC class
- Lanreotide
- Defined daily dose
- 3 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5036611000073
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
157 interactions on record for lanreotide.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lanreotide · interactions on record
157 records
- 2 severe
- 151 moderate
- 4 minor
Most severe, free to view
- LonafarnibA16AX20severe
- PexidartinibL01EX15severe
- LiraglutidA08AX02moderate
- SemaglutidA08AX03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lanreotide in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenLanreotid Amdipharm 120 mg Injektionsvätska, lösning i förfylld sprutaAmdipharm Limited
- NetherlandsLanreotide SUN 120 mg oplossing voor injectie in een voorgevulde spuitSun Pharmaceutical Industries Europe B.V.
- SpainLANREOTIDA SUN 120 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFGSun Pharmaceutical Industries (Europe) B.V.
- PolandLanreotide RanbaxyRanbaxy (Poland) Sp. z o.o.
- IrelandLanreotide SUN 120 mg solution for injection in a pre-filled syringeSun Pharmaceutical Industries Europe B.V.
- NorwayIpstyl AutogelInstitut Produits Synthèse (IPSEN) AB
- FranceMYRELEZ L.P. 120 mg, solution injectable à libération prolongée en seringue préremplieAMDIPHARM
- GermanyLanreotid SunSun Pharmaceuticals Germany Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Lanreotid Sun Pharma, Lanreotid Viatris
- Belgium · Lanreotide Sun, Lanreotide Viatris
- Cyprus · Somatuline Autogel
- Czechia · Lanreotid Sun, Lanreotid Zentiva
- Germany · Lanreotid Sun, Lanreotid Viatris
- Denmark · Ipstyl Autogel, Lanreotid Amdipharm Limited
- Estonia · Myrelez, Somatuline Autogel
- Spain · Lanreotida Sun, Lanreotida Zentiva
- Finland · Lanreotid Sun, Lanreotid Zentiva
- France · Lanreotide L.P. Biogaran, Lanréotide Viatris Lp
- Greece · Lanrod, Myrelez
- Hungary · Lanreotid Sun, Somatuline Autogel
- Ireland · Lanreotide Sun, Lanreotide Viatris
- Italy · Ipstyl, Lanrenet
- Lithuania · Myrelez, Somatuline Autogel
- Luxembourg · Somatuline Autogel Injectable, Somatuline Autogel Injectable120
- Latvia · Myrelez, Somatuline Autogel
- Netherlands · Lanreotide Sun, Mytolac
- Norway · Ipstyl Autogel, Lanreotid Sun
- Poland · Lanreotide Zentiva, Myrelez
- Portugal · Myrelez, Somatulina Autogel
- Romania · Lanreotidă Terapia, Lanreotidă Zentiva
- Sweden · Lanreotid Amdipharm, Lanreotid Sun
- Slovenia · Somatuline Autogel
- Slovakia · Lanreotid Sun, Lanreotid Zentiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f6095ed5-bfc4-46e9-ac62-7a31c657bdf0 GET /v1/drugs/f6095ed5-bfc4-46e9-ac62-7a31c657bdf0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4015711000001102",
"desc": "Somatuline Autogel 90mg/0.3ml solution for injection pre-filled syringes (Ipsen Ltd)",
"form": "Solution for injection",
"vpid": "4027111000001104",
"source": "dmd",
"vtm_id": "776474006",
"strength": "300 mg",
"substance": "Lanreotide",
"ingredient": "Lanreotide acetate",
"supplier_code": "3394701000001100"
}See everything about lanreotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.